ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

St. Jude Begins $100 Million Expansion Program

December 4, 1987

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Bill Introduced To Ban Smoking From All Flights

March 24, 1989

In Brief: Margaret Holms Names Centers Branch Chief; Kimes To Recruit As Special Assistant

March 30, 1990

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011